Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test
1. Guardant Health's Reveal test gains Medicare coverage for CRC monitoring. 2. Coverage expands use beyond early post-surgical settings to general surveillance. 3. Analyst notes reimbursement will support growth and reduce cash burn. 4. Bill Blair sees this development positively impacting stock performance. 5. Stock price surged 21.1% following the announcement.